Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Webinar to be hosted on the future of pharma industry
The Future Career Conversations series, jointly organised by SRM Institute of Science & Technology and The Hindu, will host the sixth webinar in this series, ‘Pharma 2030: Innovation, Regulation and the Rise of India' on May 3 at 11.30 a.m.
Watch Sun Pharma, Lilly Lead Latest Healthcare Deal Rush
Sun Pharma, Lilly Lead Latest Healthcare Deal Rush Bloomberg's Scarlet Fu on 'Bloomberg Deals' wraps up recent pharma dealmaking. Eli Lilly agreed to buy closely held Ajax Therapeutics for as much as $2.3 billion in cash. Sun Pharmaceutical…
Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case
Purdue Pharma, which makes OxyContin, is set to be dissolved and replaced by a company focused on the public good by the week's end, as a sweeping legal settlement resolving thousands of lawsuits takes effect. A federal judge on Tuesday delivered a…
AstraZeneca makes surprise U-turn with £300m pharma investment in UK
Britain's biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year. The drugmaker had pulled back projects in Britain after becoming disillusioned with the…
Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management
Company announcement – No. 11 / 2026 Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management Phase 3 trials for chronic weight management planned for initiation in the second half…
Avalyn Pharma Sets IPO at 16.7 Million Shares Priced at $16-$18 Each
At the $17 midpoint of that range, the Boston clinical-stage biopharmaceutical company said it expects net proceeds of about $258.7 million, or roughly $298.2 million if the underwriters exercise an option to buy an additional 2.5 million shares.
Purdue Pharma Hit With Multibillion-Dollar Reckoning for Its Role in the Opioid Crisis
On Tuesday, OxyContin manufacturer Purdue Pharma was sentenced in federal court and subjected to criminal penalties. Yet another sign that nature, and the nation, are healing. Opioid manufacturer Purdue Pharma LP (Purdue) was sentenced today in…
Court sentences Purdue Pharma to pay $5.5B, clearing settlement path
April 28 (UPI) -- A federal judge on Tuesday sentenced Purdue Pharma to pay more than $5 billion in criminal penalties, clearing the way for the OxyContin maker to complete its bankruptcy settlement agreement and resolve thousands of opioid-related…
OxyContin maker Purdue Pharma set to dissolve after judge approves sentence
A federal judge sentenced OxyContin manufacturer Purdue Pharma on Tuesday, ordering the company to pay over $5 billion in criminal penalties. The pharmaceutical company will soon dissolve, as the sentencing was the last step before Purdue Pharma…
Purdue Pharma sentenced to $5.5B in opioid criminal case
Purdue Pharma, the manufacturer of OxyContin, was sentenced in federal court on Tuesday and ordered to pay $5.5 billion for its role in fueling the opioid epidemic. The sentencing comes after Purdue pleaded guilty in 2020 on charges of deceiving…
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
Britain's largest drugmakers saw 2026 get off on a positive note, with AstraZeneca and GSK both reporting core earnings ahead of expectations on Wednesday The CEOs of a number of European pharma giants have recently said that Europe risks losing…
Purdue Pharma gets $5.5 billion sentence ahead of opioid settlement
(Reuters) – OxyContin maker Purdue Pharma was sentenced on Tuesday to $5.5 billion in fines and penalties stemming from its 2020 guilty plea to charges of deceiving government regulators and paying kickbacks to doctors to boost opioid sales.
OxyContin Maker Purdue Pharma Set to Dissolve After Judge OKs Its Criminal Sentence
Oxycodone hydrochloride (OxyContin) maker Purdue Pharma is set to be dissolved and replaced by a company focused on the public good by the week's end, as a massive legal settlement resolving thousands of lawsuits takes effect. A federal judge on…
US opioid crisis victims testify at emotional Purdue Pharma hearing
Between 1999 and 2023, around 806,000 people died from opioid overdoses in the United States, according to government data. Purdue and other opioid makers and distributors are accused of aggressively marketing prescription painkillers like…
Piramal Pharma expects FY 2027 to see a revival in growth
Piramal Pharma expects the current financial year (FY 2027) to see a revival in growth, even as geo-political uncertainties continue to cast a shadow on industry segments including pharmaceuticals. “FY27 will be a return to growth,”…
Receive a Daily briefing on Pharma Industry News
Get Started